Table 2 Comparison of CCTA results between MAFLD patients and non-MAFLD patients.

From: A clinical study of the correlation between metabolic-associated fatty liver disease and coronary plaque pattern

Characteristic

Total

MAFLD

Non-MAFLD

χ2

P

Overall plaque

922 (79.20%)

553 (81.32%)

369 (76.23%)

0.74

0.338

Calcified plaques

508 (43.64%)

320 (47.05%)

188 (38.84%)

7.76

0.005

Noncalcified plaques

206 (17.70%)

144 (21.18%)

62 (12.81%)

13.58

0.000

Mixed spots

286 (24.57%)

186 (27.35%)

100 (20.66%)

6.83

0.009

No stenosis

185 (15.89%)

101 (14.85%)

84 (17.36%)

1.32

0.034

Nonobstructive stenosis (1–49%)

677 (58.61%)

386 (56.76%)

291 (60.12%)

1.31

0.034

Obstructive stenosis (≥ 50%)

302 (25.95%)

193 (28.38%)

109 (22.52%)

5.06

0.034

Single vascular lesion (≥ 50%)

194 (16.67%)

113 (16.62%)

81 (16.74%)

0.00

0.958

Multiple vascular lesions (≥ 50%)

108 (9.28%)

80 (16.53%)

28 (5.78%)

12.01

0.004

  1. Significant values are in [bold].